Results for tag: "Striverdi Respimat"

The Striverdi Respimat market is a segment of the respiratory drugs market, which includes medications used to treat a variety of respiratory conditions. These drugs are typically inhaled, and are used to reduce inflammation and open airways in the lungs. Striverdi Respimat is a type of inhaler that delivers a slow-moving mist of medication, allowing for a more even distribution of the drug throughout the lungs. This type of inhaler is often used to treat asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. The Striverdi Respimat market is highly competitive, with many companies offering their own versions of the inhaler. Some of the major players in the market include Boehringer Ingelheim, GlaxoSmithKline, Merck, Novartis, and Pfizer. Show Less Read more